Showing results (491-500 of 539) with videos related to

Sort By:
Pageof 54
Idcases|June 27, 2018
Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature reviewJohn R Louis-Auguste, Christianne Micallef, Tim Ambrose, et al.
Journal of Neurosurgery|October 22, 2022
Continued underrepresentation of historically excluded groups in the neurosurgery pipeline: an analysis of racial and ethnic trends across stages of medical training from 2012 to 2020Elijah M Persad-Paisley, Sarah B Andrea, Owen P Leary, et al.
EJNMMI Physics|October 27, 2015
Tumor and red bone marrow dosimetry: comparison of methods for prospective treatment planning in pretargeted radioimmunotherapyWietske Woliner-van der Weg, Rafke Schoffelen, Robert F Hobbs, et al.
Frontiers in Medicine|December 8, 2015
Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer PatientsCaroline Bodet-Milin, Ludovic Ferrer, Aurore Rauscher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trialFrançoise Kraeber-Bodéré, Alain Faivre-Chauvet, Ludovic Ferrer, et al.
British Journal of Cancer|July 18, 2013
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical resultsR Schoffelen, O C Boerman, D M Goldenberg, et al.
Nature Communications|January 22, 2020
Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancyOisín Huhn, Martin A Ivarsson, Lucy Gardner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2018
Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assemblyLisa M Sharkey, Nathaniel Safren, Amit S Pithadia, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2014
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancerRafke Schoffelen, Wietske Woliner-van der Weg, Eric P Visser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid TumorsAlexander N Starodub, Allyson J Ocean, Manish A Shah, et al.
Pageof 54